New collaboration with IDSA:
Mucormycosis in India podcast
New! Patient Corner Interview:
A patient with COVID-19 and CAPA.
Featuring Dr Vazquez, Mr Castro, and his caregiver, infectious diseases nurse Angela Stroman.
New!Care Step Pathway for recognition and management of
Infographic on the recognition and management of COVID-19-associated mucormycosis
COVID-19—ASSOCIATED FUNGAL INFECTIONS EDUCATIONAL INITIATIVE
COVID-19-Associated Pulmonary Aspergillosis (CAPA) and Other COVID-19-Associated Invasive Fungal Infections (CA-IFIs)
This educational initiative was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (CFD-RFA-CK20-2003) to the University of Alabama at Birmingham. The University of Alabama at Birmingham is collaborating with the Mycoses Study Group Education & Research Consortium and Terranova Medica, LLC, on this initiative. The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.